Education
About Us
Working with TipRanks
Follow Us
Basel Medical Group Ltd (BMGL)
NASDAQ:BMGL
Total Valuation
Basel Medical Group Ltd has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
Basel Medical Group Ltd has 18,785,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,785,750
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Basel Medical Group Ltd’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 15.97%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)15.97%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.62
Inventory Turnover31.21
Valuation Ratios
The current PE Ratio of Basel Medical Group Ltd is 0.00. Basel Medical Group Ltd’s PEG ratio is ―.
PE Ratio0.00
PS Ratio0.00
PB Ratio―
Price to Fair Value0.00
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Basel Medical Group Ltd had revenue of 10.05M and earned 2.07M in profits. Earnings per share was 0.00.
Revenue10.05M
Gross Profit7.80M
Operating Income2.20M
Pretax Income2.40M
Net Income2.07M
EBITDA3.11M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Basel Medical Group Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.08
52-Week Price Change-57.97%
50-Day Moving Average3.29
200-Day Moving Average―
Relative Strength Index (RSI)39.22
Average Volume (3m)10.24M
Important Dates
Basel Medical Group Ltd upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Basel Medical Group Ltd as a current ratio of 2.26, with Debt / Equity ratio of ―
Current Ratio2.26
Quick Ratio2.25
Debt to Market Cap0.00
Net Debt to EBITDA0.75
Interest Coverage Ratio12.46
Taxes
In the past 12 months, Basel Medical Group Ltd has paid 331.76K in taxes.
Income Tax331.76K
Effective Tax Rate0.14
Enterprise Valuation
Basel Medical Group Ltd EV to EBITDA ratio is 0.75, with an EV/FCF ratio of 0.93.
EV to Sales0.23
EV to EBITDA0.75
EV to Free Cash Flow0.93
EV to Operating Cash Flow0.93
Balance Sheet
Basel Medical Group Ltd has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$0.00
Margins
Gross margin is ―, with operating margin of 21.84%, and net profit margin of 20.62%.
Gross Margin―
Operating Margin21.84%
Pretax Margin23.92%
Net Profit Margin20.62%
EBITDA Margin30.94%
EBIT Margin25.68%
Analyst Forecast
The average price target for Basel Medical Group Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―